US Patent Issued to HAMAD BIN KHALIFA UNIVERSITY on April 29 for "Generation of induced pluripotent stem cells (IPSCs) with GLUT2 mutation or FOXA2 deletion, methods of preparing same, and methods of using same" (Qatari Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,645, issued on April 29, was assigned to HAMAD BIN KHALIFA UNIVERSITY (Doha, Qatar).

"Generation of induced pluripotent stem cells (IPSCs) with GLUT2 mutation or FOXA2 deletion, methods of preparing same, and methods of using same" was invented by Essam M. Abdelalim (Doha, Qatar), Ahmed K. Elsayed (Doha, Qatar) and Khalid Hussain (Doha, Qatar).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to the method of generating human induced pluripotent stem cells (hiPSC) from patients with either heterozygous deletion of the FOX2A gene or GLUT2 (SLC2A2) gene mutations. The methods disclosed herein generate human cell mod...